AIDS, HIV Infections
Conditions
Keywords
AIDS treatment, HAART adherence, intervention
Brief summary
All eligible patients will be invited to use electronic monitoring of medication (MEMS) during the next six months. After two months with MEMS the enrolled patients will be randomized to intervention group or to control group. The intervention group will be submitted to four social-psycho sessions with a pre-trained health professional. The control group will receive the usual care of the health service. The study will compare the rate of adherence to antiretroviral therapy between the intervention group and the control group. The duration of the study will be of six months. The analysis will be based on intention-to-treat.
Interventions
BEHAVIORALSocial-psycho intervention to improve adherence to HAART
The intervention focus on the notion of scenes and scenarios to examine and discussing the experience of taking ARV medicines. In principle, such an approach provides a tool for conscientization, action and the invention of novel group and individual repertoires that may result in individual mobilization for improving adherence to treatment and reducing his/her vulnerability.
OTHERUsual care
The control group will be submitted to the usual care of the health service
Sponsors
Fundação de Amparo à Pesquisa do Estado de São Paulo
University of Sao Paulo
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients aged more than 18 years old, with detectable viral load and more than six months under HAART
Exclusion criteria
* Pregnant women * Patients participating in other trials * Patients in treatment for hepatitis and for active opportunistic infection * Patients with mental or physical condition which do not allow their attendance to the health service
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adherence to HAART | 24 weeks |
Secondary
| Measure | Time frame |
|---|---|
| Viral Load | 12 and 24 weeks |
Countries
Brazil
Outcome results
None listed